A 71-Year-Old Woman With Ovarian Cancer

Expert Leslie Randall, MD, discusses the case of a 71-year-old woman who is diagnosed with ovarian cancer. Dr. Randall reviews data with PARP inhibitors and rationale for use of maintenance therapy in patients with platinum-sensitive disease.

EP. 1: Ovarian Cancer Patient Case: Prognosis and Molecular Testing

March 17th 2022

Expert Leslie Randall, MD, discusses the case of a 71-year-old woman who is diagnosed with ovarian cancer. Dr. Randall reviews data with PARP inhibitors and rationale for use of maintenance therapy in patients with platinum-sensitive disease.

EP. 2: Maintenance Therapy Selection and Use in Ovarian Cancer

March 17th 2022

A broad look at maintenance therapy selection and its use in ovarian cancer to improve patient outcomes.

EP. 3: Considering PARP Inhibitor Maintenance in Ovarian Cancer

March 17th 2022

Shared insight on the selection of PARP inhibitors for maintenance therapy in ovarian cancer with deference to patient and disease factors.

EP. 4: PARP Inhibition in Ovarian Cancer: Safety Profiles and Dose Adjustment

March 17th 2022

Focused discussion on the safety profiles of PARP inhibitors in ovarian cancer and how these can be mitigated with proper dose management.

EP. 5: Recurrent Ovarian Cancer: Treatment Options and Maintenance Therapy

March 17th 2022

Leslie Randall, MD, considers the possibility of relapse in ovarian cancer and reviews treatment options available at recurrence.

EP. 6: Ovarian Cancer: Future Directions in Care

March 17th 2022

Closing out her discussion on ovarian cancer, Leslie Randall, MD, shares closing advice for community physicians on optimal treatment strategies.